Colchicine 0.5 mg (Takata) — 100 tablets
Colchicine 0.5 mg (Takata) is a well-established anti-inflammatory medication widely used for the treatment of acute gout attacks, prevention of recurrence, and management of certain autoinflammatory conditions such as familial Mediterranean fever (FMF). The active substance, colchicine, works at the cellular level by disrupting microtubule formation and inhibiting neutrophil activity.
Unlike traditional NSAIDs, colchicine directly targets the воспалительный process by preventing the accumulation of uric acid crystals and suppressing inflammatory cell migration. This makes it particularly effective in gout-related inflammation.
Mechanism of action
Colchicine interferes with intracellular microtubules, leading to:
Indications
The medication is used for:
Advantages of Takata formulation
Pharmacokinetics
After oral administration, colchicine is rapidly absorbed from the gastrointestinal tract, with effects beginning within hours and peaking within 24 hours. It is metabolized in the liver and primarily excreted through the intestines.
Due to its narrow therapeutic index, careful dosing is essential to avoid toxicity.
Usage considerations
Dosage and duration depend on the condition being treated. Acute gout requires a different regimen than long-term preventive measures.
How does colchicine work in gout?
It reduces inflammation caused by uric acid crystals and helps control pain.
When should it be taken?
As early as possible during a gout attack or regularly for prevention.
Can it be used long-term?
Yes, especially for prevention or FMF, under medical supervision.
What happens in case of overdose?
Overdose can cause serious toxicity, including gastrointestinal and muscle damage.
What are the most common side effects?
Diarrhea, nausea, abdominal pain; less commonly muscle weakness or blood disorders.
Who should avoid colchicine?
Patients with severe liver or kidney impairment or hypersensitivity to the drug.
Ask a question or inquire about delivery to your country